Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve

NCT03249272 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Sponsor withdrew funding

Conditions

Hypertrophic Cardiomyopathy
Non-ischemic Dilated Cardiomyopathy
Microvascular Ischaemia of Myocardium

Interventions

DRUG: Regadenoson
DRUG: Adenosine

Sponsor

Duke University